March - 2022
| Past Months | Showing Journal 1 of 1 |
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19REMAP-CAP Writing Committee for the REMAP-CAP Investigators JAMA, 2022, 327(13):1247-1259 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
March |
Previous Comments
No Comments yet.
Comment
Thrombotic events are a common feature of COVID-19 infection, even with standard thromboprophylaxis. This study arm of the REMAP CAP study sets out to answer the question, does antiplatelet therapy administered to critically ill patients with COVID-19 improve organ support–free...